Fundraising FoxFuture Ventures — 2016 Investments
2 investments dated 2016 · listed companies and verified rows first · show all
GlycosBio conducts research and development using engineered lipid technologies to improve the bioavailability and therapeutic performance of natural bioactive molecules, including approaches targeting the intestinal, pulmonary, and skin microbiota.
BiotechDeep TechHealthtechHouston, US
Richard C. Jr. Cilento(Executive Officer, Director)
BoardDan Watkins(Director)Frank Foster(Director)inJoseph Walowski(Director)Victoria Niklas(Director)
Board seatSteve Jurvetson· per SEC Form D · $930K raise · filed Jan 2017
Co-investorsGideon Hixon FundGreen Park & Golf VenturesTexas HALO FundMercury Fund
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.